Status:
COMPLETED
Determination of Performance Characteristics of the MassPLEX Factor II/V Leiden Test
Lead Sponsor:
Sequenom, Inc.
Conditions:
Factor V Leiden
Factor II
Eligibility:
All Genders
18+ years
Brief Summary
To establish the overall agreement of the MassPLEX Factor II and Factor V Leiden Genotyping Test with bi-directional DNA sequencing for Factor II and Factor V Leiden.
Detailed Description
De-identified banked genomic DNA samples derived from whole blood from subjects with suspected thrombophilia will be collected from one or more clinical sites. Three clinical laboratory sites will ana...
Eligibility Criteria
Inclusion
- suspected thrombophilia
- 18 years of age or older
Exclusion
- none
Key Trial Info
Start Date :
May 1 2013
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
July 1 2013
Estimated Enrollment :
867 Patients enrolled
Trial Details
Trial ID
NCT01835483
Start Date
May 1 2013
End Date
July 1 2013
Last Update
January 20 2014
Active Locations (3)
Enter a location and click search to find clinical trials sorted by distance.
1
Sequenom Center for Molecular Medicine
Grand Rapids, Michigan, United States, 49503
2
Oregon Health & Science University
Portland, Oregon, United States, 97239
3
The Methodist Hospital Research Institute
Houston, Texas, United States, 77030